AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.
source https://www.cbc.ca/news/world/coronavirus-covid19-canada-world-1.6199853?cmp=rss
No comments:
Post a Comment